Combination Biomarker Benefits Patients With Advanced Bladder Cancer
A new combination of biomarkers from baseline tumor tissues was predictive of improved clinical responses and prolonged survival following treatment with immune checkpoint inhibitors in patients with advanced metastatic bladder…
